Evidence map›Paper›PMID 40076720›Full record

ArticleInternational journal of molecular sciences2025

DNA Salivary Methylation Levels of the ACE2 Promoter Are Not Related to ACE2 (

César Fernández-de-Las-Peñas, Gema Díaz-Gil, Antonio Gil-Crujera, Stella M Gómez-Sánchez, Silvia Ambite-Quesada, Juan Torres-Macho, Pablo Ryan-Murua, Ana I Franco-Moreno, Oscar J Pellicer-Valero, Lars Arendt-Nielsen and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

César Fernández-de-Las-PeñasDepartment of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain.ORCID 0000-0003-3772-9690
Gema Díaz-GilResearch Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos, 28933 Madrid, Spain.ORCID 0000-0003-3480-1490
Antonio Gil-CrujeraResearch Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos, 28933 Madrid, Spain.ORCID 0000-0002-1022-5831
Stella M Gómez-SánchezResearch Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos, 28933 Madrid, Spain.ORCID 0000-0002-7140-4286
Silvia Ambite-QuesadaDepartment of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, 28922 Alcorcón, Spain.ORCID 0000-0001-6755-8189
Juan Torres-MachoDepartment of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.ORCID 0000-0002-8860-6837
Pablo Ryan-MuruaDepartment of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.ORCID 0000-0002-4212-7419
Ana I Franco-MorenoDepartment of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.ORCID 0000-0003-1061-0200
Oscar J Pellicer-ValeroImage Processing Laboratory (IPL), Universitat de València, Parc Científic, 46100 Paterna, Spain.ORCID 0000-0002-0104-1029
Lars Arendt-NielsenCenter for Neuroplasticity and Pain (CNAP), Sensory-Motor Interaction (SMI) Center, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.ORCID 0000-0003-0892-1579
Rocco GiordanoCenter for Neuroplasticity and Pain (CNAP), Sensory-Motor Interaction (SMI) Center, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.ORCID 0000-0003-1331-129X

Funding

Comunidad de Madrid THE LONG COVID EX CMNovo Nordisk Foundation NNF21OC0067235
6 · The paper itself

Abstract

Genetics and epigenetics are mechanisms proposed for explaining post-COVID-19 condition. This secondary analysis aimed to investigate if DNA methylation levels of the ACE2 promoter are different depending on the genotype of five COVID-19-related polymorphisms in individuals who had been previously hospitalized due to SARS-CoV-2 infection. We collected non-stimulated saliva samples from 279 (48.7% female, age: 56.0 ± 12.5 years) previously hospitalized COVID-19 survivors. The participants self-reported for the presence of post-COVID symptomatology that started after the infection and persisted at the time of the appointment. Three potential genotypes of ACE2

Indexed as

Angiotensin-Converting Enzyme 2COVID-19DNA MethylationPolymorphism, Single NucleotideSalivaSerine EndopeptidasesAdultAgedFemaleGenotypeHumansMaleMiddle AgedPromoter Regions, GeneticSARS-CoV-2SurvivorsACE2 protein, humanAngiotensin-Converting Enzyme 2Serine EndopeptidasesTMPRSS2 protein, humanACE1ACE2long COVIDmethylationpolymorphismTMPRSS2

Identifiers

PMID40076720
PMCPMC11900996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.